Robert Andrade, CHIEF FINANCIAL OFFICER at FENNEC PHARMACEUTICALS INC. (FENC), sold 22,000 shares at $9.61 ($211K) on 2022-12-30, disclosed to the SEC on 2022-12-30.
Open-market sale of $211k FENC by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.61 | 11,000 | $106K | 50.1% |
| 2 | $9.57 | 5,500 | $53K | 24.9% |
| 3 | $9.61 | 5,500 | $53K | 25.0% |
| Total | $9.60 avg | 22,000 | $211K | 100% |
| Filing → |
| FENC | SELL | 2024-03-25 | $154K | — | Filing → |
| FENC | SELL | 2024-01-05 | $316K | — | Filing → |
| FENC | SELL | 2023-06-30 | $223K | — | Filing → |